With the analysis among 66,101 patents, we discovered top 454 key players by total patent application. Genentech, Inc., F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc. are dominant in this area. They take 11.01% of the total patent filing.
California, United States
Patent: 3,077
F. Hoffmann-La Roche Ltd.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 1,940
Basel-Stadt, Switzerland
Patent: 1,522
California, United States
Patent: 1,100
New York, United States
Patent: 993
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 869
Indiana, United States
Patent: 814
New Jersey, United States
Patent: 745
With the analysis among 3,071 patents, we discovered top 301 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Forty Seven, Inc., Phanes Therapeutics, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 111
Phanes Therapeutics, Inc.
California, United States
Patent: 100
Herefordshire, United Kingdom
Patent: 71
Washington, United States
Patent: 65
Eucure (Beijing) Biopharma Co., Ltd.
Beijing Shi, China
Patent: 61
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 50
Marengo Therapeutics, Inc.
Massachusetts, United States
Patent: 50
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 49
California, United States
Patent: 46
With the analysis among related 46,542 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Genentech, Inc. take 7.58% of patent filing during this period.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 1,364
F. Hoffmann-La Roche Ltd.
California, United States
Patent: 1,042
Basel-Stadt, Switzerland
Patent: 843
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 687
California, United States
Patent: 624
New York, United States
Patent: 563
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 553
Indiana, United States
Patent: 522
With the analysis among related 46,542 patents in last 5 years, we discover 108 new entrants. Phanes Therapeutics, Inc., Silverback Therapeutics, Inc., Denali Therapeutics, Inc. are the most active new entrants in this area.
Phanes Therapeutics, Inc.
California, United States
Patent: 100
Silverback Therapeutics, Inc.
Washington, United States
Patent: 81
Denali Therapeutics, Inc.
California, United States
Patent: 77
Shenzhou Cell Engineering Co Ltd.
Beijing Shi, China
Patent: 76
Herefordshire, United Kingdom
Patent: 71
Jiangsu Hansoh Pharmaceutical Co. Ltd.
Jiangsu Sheng, China
Patent: 70
Shanghai Hansoh Biomedical Co. Ltd.
Shanghai Shi, China
Patent: 68
Dongguan Pengzhi Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 66
Kindred Biosciences, Inc.
California, United States
Patent: 57
With the analysis among 11,408 patents, we discovered top 232 universities and scientific research institutions by total patent application. Osaka University, The Scripps Research Institute, The Rockefeller University are dominant in this area. They take 12.35% of the total patent filing.
Osaka-fu, Japan
Patent: 157
The Scripps Research Institute
California, United States
Patent: 131
The Rockefeller University
New York, United States
Patent: 126
New York, United States
Patent: 111
The Johns Hopkins University
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 103
Université d'Aix-Marseille
President & Fellows of Harvard College
Massachusetts, United States
Patent: 102
Tokyo-to, Japan
Patent: 97
ZURICH, Switzerland
Patent: 92